Just two drugs are widely approved to slow Alzheimer's — Eli Lilly's Kisunla and Leqembi from Eisai and Biogen.

A bacteria best known for causing stomach ulcers could lead to a new strategy in the fight against Alzheimer’s disease

Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer's dis...

For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit and finally, her...

Liraglutide - sold under the brand name Saxenda - is often offered to people with with a BMI of over 30 as it improves blood sugar control a...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the drugs affect th...

Novo Nordisk has announced the failure of its Alzheimer's trials, where an older oral version of their semaglutide drug did not succeed in s...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

Data provides new insights into targeting the diverse pathobiology of Alzheimer's disease, an approach spearheaded by the ADDF NEW YORK, Nov...

By Jamie Gumbrecht, CNN(CNN) — An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to s...

When actor Chris Hemsworth, who played Thor in the Marvel series, agreed to join a documentary exploring longevity several years ago, he fig...

A panel of academics, doctors and patients examined 80 existing treatments to identify those mostly likely to help tackle Alzheimer's - for...

Scientists hail ‘very exciting’ findings that explain why Alzheimer’s patients forget their loved ones, and say drugs are already available...

HONG KONG, Nov. 16, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both am...

Bill Gates wants to add a new element to routine medicals for Americans over the age of 60: Blood tests that identify whether the patient ma...